Skip to main content
. 2020 Nov 17;14:5029–5041. doi: 10.2147/DDDT.S266470

Table 5.

Liver Toxicity 48 Hours and One Month After TACE Session

DEB-TACE c-TACE +HA
(n=32)
–HA
(n=29)
p-value
+HA
(n=23)
–HA
(n=19)
p-value +HA
(n=9)
–HA
(n=10)
p-value
Liver toxicity 48 h after TACE
Bilirubin
(grade 1/2)
5/6 5/4 0.904 3/2 3/3 0.929 8/8 8/7 0.974
AST
(grade 1/2/3/4)
6/3/9/2 5/2/1/0 0.011 0/2/5/1 3/0/0/0 0.004 6/5/14/3 8/2/1/0 <0.001
ALT
(grade 1/2/3/4)
8/1/8/0 5/1/0/0 0.012 3/3/0/1 0/0/0/0 0.006 11/4/8/1 5/1/0/0 <0.001
Liver toxicity one month after TACE
Bilirubin
(grade 1/2)
8/2 5/2 0.788 4/0 1/1 0.209 12/2 6/3 0.339
AST
(grade 1/2/3/4)
6/0/0/0 5/1/0/0 0.552 1/0/0/0 2/0/0/0 0.500 7/0/0/0 7/1/0/0 0.545
ALT
(grade 1/2/3/4)
4/0/0/0 2/0/0/0 0.668 0/0/0/0 1/0/0/0 0.500 4/0/0/0 3/0/0/0 1.000

Abbreviations: +HA, concurrent chemoembolization of hepatic and EHC tumor feeding arteries; –HA, chemoembolization of only extrahepatic tumor feeding arteries; ALT, alanine transaminase; AST, aspartate transaminase; cTACE, conventional transarterial chemoembolization; DEB-TACE, drug-eluting beads transarterial chemoembolization; TACE, transarterial chemoembolization.